Recital 12, Regulation (EU) 2024/2781

In forcesince 31 Oct 2024

For the active substance fluroxypyr, as the Authority needs additional time to reach a conclusion on the risk assessment after the two additional months necessary to finalise the public consultation pursuant to Article 12 of Implementing Regulation (EU) 2020/1740, and in light of the time required to complete the remaining steps in the renewal procedure, the extension of the approval period for this active substance should be set at 25 months and 2 weeks.